Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Nutrition Sciences N V has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 2 pending office actions involve 2 distinct examiners and 2 distinct art units. LEE, WILLIAM Y is the busiest examiner, holding 1 busiest examiner pending action. The use of 2 distinct art units shows that the pending applications are categorized into different technical groups.
With 2 distinct examiners, the prosecution process is not centralized under a single individual. This requires the applicant to navigate the different examination styles of 2 distinct examiners within the Biotechnology & Pharmaceuticals sector. The 2 pending office actions are split between these examiners, with LEE, WILLIAM Y responsible for 1 busiest examiner pending action. This distribution indicates that the company is active in multiple areas of biotechnology. Managing 2 distinct art units requires an understanding of the specific standards within each unit. The current data shows a balanced portfolio with no single examiner dominating the entire pending workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, WILLIAM Y | 1 | 47.9% | +34.1% |
| BURKETT, DANIEL JOHN | 1 | 62.6% | +33.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909979 | Composition for Use in the Prophylaxis and Treatment of Viral Infections of the Asfarviridae Family | BURKETT, DANIEL JOHN | 32d overdue |
| 18280357 | Pelargonic Acid for Use Against Viral Infections | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18280357 | Pelargonic Acid for Use Against Viral Infections | LEE, WILLIAM Y | 1623 | §102§103DP | Non-Final OA | — | Pending | Sep 05, 2023 |
| 17909979 | Composition for Use in the Prophylaxis and Treatment of Viral Infections of the Asfarviridae Family | BURKETT, DANIEL JOHN | 1624 | §103§112DP | Non-Final OA | 32d overdue | Pending | Sep 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial